Nitrofurantoin
pharmaceutical drug
Nitrofurantoin, sold under the brand name Macrobid among others, is an antibacterial medication of the nitrofuran class. It is used primarily to treat lower urinary tract infections (UTIs) but it is also used in bladder infections. It is not indicated for kidney infections nor is it as effective for them. It is taken by mouth.
Common side effects include nausea, loss of appetite, diarrhea, and headaches. Rarely numbness, lung problems, or liver problems may occur. While it appears to be generally safe during pregnancy its use is not recommended near time of delivery. While it usually works by slowing bacterial growth, it may result in bacterial death at the high concentrations found in urine, provided forced fluid dilution of urine is avoided.
As the name or branding suggests, nitrofurantoin (due to the brand name macrobid) should be taken twice per day, or bis in die (B.I.D.). Nitrofurantoin was first sold in 1953.
Begin with the source’s own compact description: “Nitrofurantoin” is pharmaceutical drug. The dossier treats that line as a proposition to test through Nitrofurantoin, pharmaceutical and drug, not as a finished interpretation.
Why this record matters
The phrase “pharmaceutical drug” supplies a clear boundary for inquiry. It also exposes the unanswered questions: who defined that boundary, when it became stable and which sources sit outside it.
Named sources, stable identifiers and responsible institutions provide the strongest route from overview to verifiable evidence. The source revision retrieved here is dated Jul 25, 2026. The linked authority identifier is Q422669. None of the 0 selected statements returned an explicit reference. The first chronological checks are 1953.
The absence of detail may reflect summary conventions rather than a lack of surviving documentation. The source lead contains qualifying language; that uncertainty should survive quotation, summary and reuse. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.
- Subject orientation
- Search vocabulary
- Locating named sources
The closest primary source, responsible institution and strongest cited specialist reference.
Three-step research path
- Establish the record: confirm the title “Nitrofurantoin”, its source revision and the description used here.
- Expand the search: follow Nitrofurantoin primary sources, Nitrofurantoin archive and Nitrofurantoin research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Nitrofurantoin”?
- Which cited source is closest to the event, object or claim?
- What terminology or title could unlock a more precise catalogue search?
Search terms from this dossier
This entry incorporates text from “Nitrofurantoin” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.